Innovation

Despite declining pandemic-driven demand, BioNTech reported an EPS of €1.08, surpassing analyst expectations. The company transitions from COVID-19 vaccine manufacturing to pioneering oncology solutions, aiming to launch its first cancer…

The "SAFE" initiative is transforming workplace environments, focusing on Safety, Affinity, Fulfillment, and Engagement to enhance employee satisfaction and well-being. The prestigious "SAFE Award" celebrates companies that exemplify these ideals…